Roll up the Sleeves! When the bell rang at previous close ASLAN Pharmaceuticals Limited (ASLN) was up 7.65% – Invest Chronicle
Home  »  Stock   »  Roll up the Sleeves! When the bell rang at previou...

Roll up the Sleeves! When the bell rang at previous close ASLAN Pharmaceuticals Limited (ASLN) was up 7.65%

Let’s start up with the current stock price of ASLAN Pharmaceuticals Limited (ASLN), which is $0.46 to be very precise. The Stock rose vividly during the last session to $0.55 after opening rate of $0.4262 while the lowest price it went was recorded $0.425 before closing at $0.43.Recently in News on June 7, 2022, ASLAN Pharmaceuticals Initiates Scientific Collaboration to Investigate the Distinct Role of IL-13 Receptor Signaling in Atopic Dermatitis. ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it has initiated a research collaboration with Dr Shawn Kwatra, as an advisor, from Johns Hopkins University School of Medicine and Dr Madan Kwatra from Duke University Medical Center to investigate the unique role of the IL-13Ra1 subunit, distinct from the role of other pathway components, in Type 2-mediated inflammatory diseases, specifically atopic dermatitis (AD). You can read further details here

ASLAN Pharmaceuticals Limited had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.2300 on 01/05/22, with the lowest value was $0.3555 for the same time period, recorded on 06/06/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


ASLAN Pharmaceuticals Limited (ASLN) full year performance was -86.34%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ASLAN Pharmaceuticals Limited shares are logging -87.99% during the 52-week period from high price, and 28.69% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.36 and $3.81.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 525173 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the ASLAN Pharmaceuticals Limited (ASLN) recorded performance in the market was -59.15%, having the revenues showcasing -46.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 32.04M, as it employees total of 27 workers.

Analysts verdict on ASLAN Pharmaceuticals Limited (ASLN)

During the last month, 0 analysts gave the ASLAN Pharmaceuticals Limited a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 0.7061, with a change in the price was noted -0.45. In a similar fashion, ASLAN Pharmaceuticals Limited posted a movement of -49.43% for the period of last 100 days, recording 223,038 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ASLN is recording 0.81 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.81.

ASLAN Pharmaceuticals Limited (ASLN): Technical Analysis

Raw Stochastic average of ASLAN Pharmaceuticals Limited in the period of last 50 days is set at 20.63%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.44%. In the last 20 days, the company’s Stochastic %K was 34.79% and its Stochastic %D was recorded 24.68%.

Let’s take a glance in the erstwhile performances of ASLAN Pharmaceuticals Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -59.15%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -61.88%, alongside a downfall of -86.34% for the period of the last 12 months. The shares increased approximately by 17.01% in the 7-day charts and went up by 2.35% in the period of the last 30 days. Common stock shares were lifted by -46.80% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts